Post-transplant patients off steroids have fewer cardiovascular events
May 8th, 2010 - 4:05 pm ICT by ANIWashington, May 8 (ANI): Post-transplant patients, who have given up corticosteroid regimen, have fewer cardiovascular events than those on steroids, increasing their graft survival rates and reducing early mortality, University of Cincinnati (UC) transplantation researchers have found. Corticosteroids are commonly given to post-transplant patients as part of an immunosuppressive regime to promote graft survival.
But the steroids also cause harmful cardiovascular side effects such as increased blood pressure, cholesterol and weight gain, said Dr Rita Alloway.
The researchers have largely focused on reducing patient exposure to corticosteroids during post-transplantation treatment.
“Ten years ago, almost 80 percent of post-transplant kidney patients were discharged from the hospital on steroids. Now, according to United Network for Organ Sharing (UNOS) reports, less than 20 percent are discharged from the hospital on steroids. We’ve effectively removed chronic steroids from the immunosuppressive regimen while maintaining similar graft survival outcomes,” said Alloway.
In the study, led by Dr. Adele Rike Shields, researchers are now able to show patients removed from a steroid treatment have decreased cardiovascular events after transplant, in addition to their lowered side effects.
Shields evaluated acute graft rejection and graft loss in 630 kidney transplant patients withdrawn from corticosteroids.
She found the risk factors in the corticosteroid-withdrawn kidney transplant population are similar to those traditionally defined under conventional immunosuppression with steroids.
“With the summation of 10 years of work, we’ve been able to show that patients off corticosteroids have the same graft-function outcomes as patients on corticosteroids. In addition, the patients off corticosteroids benefit from fewer cardiovascular events,” said Alloway.
The researchers are presenting the study at the American Transplant Congress (ATC), the annual meeting of the American Society of Transplantation. (ANI)
- Experimental drug better for kidney transplant - Mar 04, 2010
- New test quickly detects kidney transplant rejection - Feb 18, 2010
- Genes can tell which kidney transplant recipients don't need lifelong drugs - May 25, 2010
- Novel drug for kidney transplant effective in humans - Feb 18, 2010
- Faith in God improves survival after liver transplantation - Oct 01, 2010
- Too thin, too fat 'at increased death risk' post liver transplant - Aug 05, 2009
- Moderate alcohol intake may benefit kidney transplant patients - Nov 19, 2010
- Stem cells may help treat aggressive multiple sclerosis - Mar 22, 2011
- Earlier not necessarily better for pre-emptive kidney transplants - Oct 30, 2009
- Short-term success of male to female kidney transplants 'doubtful' - Jul 30, 2009
- Sleep apnea ups heart disease risk in kidney transplant patients - Nov 20, 2009
- Inhaled steroids up diabetes risk: Study - Nov 02, 2010
- Organ seekers on social networks more successful - May 24, 2012
- Mums' stem cells could be key to treating genetic disease before birth - Jan 19, 2011
- Weight plays key role in kidney transplants - May 23, 2010
Tags: acute graft rejection, adele, cardiovascular events, cardiovascular side effects, corticosteroids, graft function, graft loss, graft survival rates, immunosuppression, immunosuppressive regimen, kidney patients, kidney transplant patients, rike, risk factors, steroid treatment, steroids, survival outcomes, transp, united network, university of cincinnati